What happens when private general practitioners receive incentivisation offers from pharmaceutical sales representatives? A qualitative study in Pakistan

Muhammad Naveed Noor,Afifah Rahman-Shepherd,Sabeen Sharif Khan,Rumina Hasan,Amna Rehana Siddiqui,Iqbal Azam,Faiza Bhutto,Afshan Khurshid Isani,Sameen Siddiqi,Robyna Irshad Khan,Sadia Shakoor,Mishal Khan
DOI: https://doi.org/10.1177/13558196241230853
2024-02-02
Journal of Health Services Research & Policy
Abstract:Journal of Health Services Research &Policy, Ahead of Print. ObjectivesPharmaceutical incentivisation of physicians for profit maximisation is a well-documented health system challenge. This study examined general practitioners' (GPs) reactions to pharmaceutical incentivisation offers in one region in Pakistan.MethodsWe used the Standardised Pharmaceutical Sales Representative (SPSR) method and qualitative interviews with GPs. SPSRs were field researchers representing mock pharmaceutical companies who recorded their observations of 267 GPs' responses to pharmaceutical incentivisation offers. We triangulated SPSR data using qualitative interviews with a subset of the same GPs to gather information about how they interpreted different interaction outcomes.ResultsWe found four major outcomes for GPs being offered incentives by pharmaceutical companies for prescribing medications. GPs might agree to make incentivisation deals, reject incentivisation offers, disallow PSRs to access them, or remain indeterminate with no clear indication of acceptance or rejection of incentivisation offers. GPs rejecting SPSRs' incentivisation offers indicated having active commitments to other pharmaceutical companies, not being able to work with unheard-of companies, and asking SPSRs to return later.ConclusionsThe GP-pharmaceutical sales representative interaction that centres on profit-maximisation is complex as offers to engage in prescribing for mutual financial benefit are not taken up immediately. The SPSR method helps understand the extent of distortion of practices impacted by incentivisation. Such an understanding can support the development of strategies to control unethical behaviours.
health policy & services
What problem does this paper attempt to address?